Table of contents

Original Articles

• Introduction (1 July, 2001)

  Jan B. Vermorken, Andres Poveda
• Ovarian cancer screening in the general population: current status (1 July, 2001)

  U. Menon, I. J. Jacobs
• The role of molecular biology in understanding ovarian cancer initiation and progression (1 July, 2001)

  C. Bingham, D. Roberts, T. C. Hamilton
• Early stage ovarian cancer: the Italian contribution to clinical research. An update (1 July, 2001)

  G. Favalli, F. Odicino, V. TORRI, S. Pecorelli
• Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument (1 July, 2001)

  C. Tropé, J. Kaern, T. Hogberg, V Abeler, B. Hagen, G. Kristensen, M. Onsrud, E. Pettersen, P. Rosenberg, R. Sandvei, K. Sundfor, I. Vegote
• The integration of paclitaxel and new platinum compounds in the treatment of advanced ovarian cancer (1 July, 2001)

  J. B. Vermorken
• The integration of docetaxel into first-line chemotherapy for ovarian cancer (1 July, 2001)

  S. B. Kaye
• The integration of anthracyclines in the treatment of advanced ovarian cancer (1 July, 2001)

  H.-J. Lück, A. Du Bois, B. Weber, J. Pfisterer, A. Goupil, W. Kuhn, J. C. Barats, J. Blohmer, M. Mousseau, W. Schröder, W. Meier, V. Möbus, B. Richter
• Gemcitabine in the treatment of ovarian cancer (1 July, 2001)

  S. W. Hansen
• Developmental chemotherapy in advanced ovarian cancer: Incorporation of topoisomerase-I inhibitors and perspective of the Gynecologic Oncology Group (1 July, 2001)

  M. A. Bookman
• Second-line treatment and consolidation therapies in advanced ovarian cancer (1 July, 2001)

  P. F. Conte, A. Gadducci, C. Cianci
• Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer (1 July, 2001)

  E. D. Hager, H. Dziambor, D. Höhmann, N. Mühe, H. Strama
• High dose chemotherapy in ovarian cancer (1 July, 2001)

  E. Pujade-Lauraine, H. Curé, C. Battista, J. P. Guastalla, B. Chiurazzi, M. Fabbro, N. Tubiana-Mathieu, H. Bourgeois, B. Lioure, D. Paraiso, J.P. Lotz
• Impact of new non-cytotoxics in the treatment of ovarian cancer (1 July, 2001)

  E. Eisenhauer, J. Dancey
• Intergroup collaboration in ovarian cancer: the Gynecologic Cancer Intergroup (GCIG) (1 July, 2001)

  J.B. Vermorken
• Remarks and conclusions on ovarian cancer treatment (1 July, 2001)

  A. Poveda